Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfer factor treatment in bullous pemphigoid. Impaired T cell function.

A Khan, R Ayyar, J D Michaelson

    Dermatologica
    |January 1, 1980
    PubMed
    Summary

    Transfer factor (TF) therapy improved cellular immunity in a bullous pemphigoid patient unresponsive to prednisone. This immune enhancement led to sustained remission of skin lesions and normalized T cell function.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2001
    Same author

    Measurement of CP-violating asymmetries in B0 decays to CP eigenstates.

    Physical review letters·2001
    Same author

    The placebo enigma in antidepressant clinical trials.

    Journal of clinical psychopharmacology·2001
    Same author

    Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.

    Diabetes·2001
    Same author

    Hyperglycemia contributes to impaired insulin response in GK rat islets.

    Diabetes·2001
    Same author

    O2 dependence of K+ transport in sickle cells: the effect of different cell populations and the substituted benzaldehyde 12C79.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001

    Area of Science:

    • Immunology
    • Dermatology
    • Cellular Immunity

    Background:

    • Bullous pemphigoid (BP) is an autoimmune blistering skin disease.
    • Some BP patients exhibit impaired cellular immunity and may not respond to standard treatments like prednisone.
    • Cellular immunity, particularly T cell function, plays a role in the pathogenesis of BP.